Legal Representation
Attorney
Margarita Wallach, Esq.
USPTO Deadlines
Next Deadline
115 days remaining
Statement of Use Due - Extension 5 Granted
Due Date
November 01, 2025
Application History
32 events| Date | Code | Type | Description |
|---|---|---|---|
| Jun 21, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Jun 20, 2025 | EX5G | S | SOU EXTENSION 5 GRANTED |
| May 1, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 1, 2025 | EXT5 | S | SOU EXTENSION 5 FILED |
| Oct 31, 2024 | EXT4 | S | SOU EXTENSION 4 FILED |
| Oct 31, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Oct 31, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Oct 31, 2024 | EX4G | S | SOU EXTENSION 4 GRANTED |
| May 1, 2024 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Apr 30, 2024 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Apr 30, 2024 | EXT3 | S | SOU EXTENSION 3 FILED |
| Apr 30, 2024 | EX3G | S | SOU EXTENSION 3 GRANTED |
| Nov 1, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Oct 30, 2023 | EX2G | S | SOU EXTENSION 2 GRANTED |
| Oct 30, 2023 | EXT2 | S | SOU EXTENSION 2 FILED |
| Oct 30, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 3, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| May 1, 2023 | EX1G | S | SOU EXTENSION 1 GRANTED |
| May 1, 2023 | EXT1 | S | SOU EXTENSION 1 FILED |
| May 1, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| Nov 1, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Sep 6, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Sep 6, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Aug 17, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Jul 29, 2022 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Jul 29, 2022 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
| Jul 29, 2022 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Jul 29, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Jul 29, 2022 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Jun 28, 2022 | DOCK | D | ASSIGNED TO EXAMINER |
| Oct 27, 2021 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Oct 1, 2021 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment of genetic disorders and diseases; genetic medicines for the treatment of genetic diseases, related diseases having a genetic cause or component and disease states resulting from gene expression or genetic sequence
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"GENE"